Stem Cell Therapy for Diabetes

The treatment of patients with diabetes mellitus may greatly benefit from the use of undifferentiated or undeveloped cells. The developmental stages and transcription factors involved in this process have been defined by research on the capacity of human embryonic undifferentiated cells to segregate into islet cells. In any event, ethical considerations as well as the possibility for teratoma formation limit the clinical applications of human embryonic stem cells.

    Related Conference of Stem Cell Therapy for Diabetes

    January 11-12, 2024

    5th Global summit on Diabetes and Endocrinology

    Dubai, UAE
    February 08-09, 2024

    33rd European Diabetes Congress

    Paris, France
    March 25-26, 2024

    5th Annual Conference on Diabetes

    London, UK

    Stem Cell Therapy for Diabetes Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in